Skip to main content
BMEA logo

BMEA · Biomea Fusion, Inc.

$1.31 +0.03 (+2.34%) At close · Jul 20
Market Cap
$94.71M
Shares
72.30M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-06-11 Expert Webinar: The Latest Therapeutic Developments for Type 1 Diabetes Post-ADA Event
2026-06-10 Virtual Annual Meeting of Stockholders Shareholder meeting
2026-06-07 Menin Inhibitor Icovamenib Activates Mechanisms That Support Metabolic Health Event
2026-06-07 Icovamenib, a Menin Inhibitor, Improves Endogenous Insulin Secretion in Type 1 Diabetes: Results from the COVALENT-112 Study Event
2026-06-07 Glycemic Improvements with Icovamenib in T2D on Background GLP-1 Therapy: COVALENT-111 Subgroup Analysis Event
2026-06-04 2026 Jefferies Global Healthcare Conference Conference
2026-05-19 H.C. Wainwright 4th Annual BioConnect Investor Conference Conference
2026-05-05 Rodman & Renshaw fireside chat with Key Opinion Leader Alex Abitbol, M.D. Event
2026-04-28 COVALENT-112: 52-Week Icovamenib Data in Type 1 Diabetes Conference Call Conference
2026-03-30 Rodman & Renshaw Fireside Chat With Management of Biomea Fusion Event
2026-03-30 JP Morgan: Addressing Top-10 Questions With Biomea Fusion Management In 30 Minutes Event
2026-03-24 BMO Metabolic Health Summit Event
2026-03-14 19th International Conference on Advanced Technologies & Treatments for Diabetes “ATTD” Conference
2026-03-10 The Citizens Life Sciences Conference Conference
2026-02-26 Oppenheimer 36th Annual Healthcare Life Sciences Conference Conference
2026-01-14 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-09 Dr. Ralph DeFronzo clinical insights from the COVALENT-111 study Event
2025-12-05 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) Presentation #0062 Presentation
2025-12-03 8th Annual Evercore Healthcare Conference Conference
2025-12-02 Piper Sandler 37th Annual Healthcare Conference Conference
2025-11-17 Jefferies London Healthcare Conference Conference
2025-11-04 ObesityWeek® 2025 Poster Presentation #136 Presentation
2025-11-04 ObesityWeek® 2025 Poster Presentation #085 Presentation
2025-10-23 Biomea Fusion to participate in Citi's 2025 SMID Cap Biopharma Call Series Event
2025-10-07 COVALENT-111 Phase II Study Icovamenib in Type 2 Diabetes – 52-Week Results Event

Source: https://investors.biomeafusion.com/

Key facts CIK 1840439 CUSIP 09077A106 13F (30d) 5 filings 5 filers Visit website Investor relations